Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CritiTech Particle Engineering Solutions | Contract Pharma

What are you searching for?

Sign in

Search by

CritiTech Particle Engineering Solutions

CritiTech Particle Engineering Solutions

Company Headquarters

1849 E. 1450 Rd. , Lawrence, KS, 66044, US

Driving Directions Phone: View Phone
View website

Company Description

CritiTech is a multi-service CDMO specializing in pre-formulation, formulation, particle engineering, analytical methods and testing, and preclinical to GMP manufacturing. We use spray drying, jet milling and our proprietary Purcision platform to engineer non-cyto, cyto, potent, and inhaled drugs. CritiTech produces fast, impactful and quality results.

Request more information from CritiTech Particle Engineering Solutions

Request more information from CritiTech Particle Engineering Solutions

Categories from CritiTech Particle Engineering Solutions

Accelerated Stability Studies
Analytical Laboratory Services
Analytical Methods Development
Analytical Validation Studies
Animal Health
API Solubilization Technologies
Assay Development
Auditing
Blending
Chemical Analysis
Chromatographic Analysis, LC/GC
Chromatography
Clinical Trials, Phase I
Clinical Trials, Phase II
Clinical Trials, Phase III
CMC (Chemistry, Manfacturing & Controls)
Consulting
Consulting, Regulatory
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Contract Research
Custom Manufacturing
Dissolution Testing
Dosage Form Development
Drug Design
Drug Development Services
Encapsulation
Feasibility Studies
Filling, Capsule
Filling, Vial
Forced Degradation Studies
Formulation Development
Formulation Services
Formulation, Controlled Release
GLP Auditing
GMP Auditing
HPLC
Imaging
IND/NDA Submissions
Lot Release Testing
Manufacturing, Capsules
Manufacturing, Clinical Trials Supply
Manufacturing, Consultants
Manufacturing, Controlled Substances
Manufacturing, Creams & Ointments
Manufacturing, Custom
Manufacturing, Cytotoxic & High Potency Compounds
Manufacturing, Dose Form, Non-Sterile
Manufacturing, Generics
Manufacturing, Inhalables
Manufacturing, Injectables
Manufacturing, Nasal Delivery
Manufacturing, Nutraceuticals
Manufacturing, Ophthalmics
Manufacturing, Oral Drug Delivery
Manufacturing, Other
Manufacturing, Parenterals, Small Volume
Manufacturing, Peptides
Manufacturing, Powders, Non-Sterile
Manufacturing, Proteins
Manufacturing, Solid Dosage
Manufacturing, Solutions & Suspensions
Manufacturing, Sustained Release
Manufacturing, Topicals
Materials Analysis
Methods Development
Methods Validation
Micro FT-IR Analysis
Micronization
Mixing & Blending
Nonclinical Research
Parenterals, Vial Filling
Particle Characterization
Particle Size Analysis
Particle Size Classification
Physical Testing
Pilot-Scale Filling
Preclinical Testing
Preclinical Testing Formulations
Preformulation
Process Characterization
Process Development/Scale-Up Services
Process R&D
Process Validation Studies
Project Management
QA/QC
Quality Control Testing
R&D Services
Raw Materials Analysis
Scale-Up
Size Reduction
Spray Drying
Stability Studies
Stability, ICH
Technology Transfer
UV-VIS Spectrophotometer Analysis
Validation, Clinical
Validation, Manufacturing
Validation, Services
X-Ray Powder Diffraction

Related Content

Collaborations & Alliances

ExploRNA, Łukasiewicz Research Network Partner on GMP Manufacturing of Next-Gen mRNA Cap Analogs

Łukasiewicz, known for advanced chemical synthesis and production scaling capabilities, will help ExploRNA ramp up its mRNA manufacturing.

By: Patrick Lavery

Breaking News

Sanner Rebrands Gilero, Expands Chicago Facility

North American expansion strengthens CDMO support for medtech and healthcare packaging.

By: Charlie Sternberg

Breaking News

WuXi XDC Secures GMP Release for Singapore Manufacturing Site

The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.

By: Patrick Lavery

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

Collaborations & Alliances

Bespak and Upperton Partner on Nasal Drug Delivery

The CDMO collaboration will combine Bespak’s nasal device portfolio with Upperton’s formulation, analytical and clinical manufacturing expertise.

By: Charlie Sternberg

Breaking News

Kincell Bio, Cellipont Merge to Form Kincellis Advanced Therapies

New advanced therapies CDMO combines immune-cell, stem-cell and mRNA-enabled capabilities across three U.S. sites.

By: Charlie Sternberg

Breaking News

Upperton Gains MHRA Approval for Nottingham Sterile Manufacturing Site

License variation supports early-phase GMP manufacture at Nottingham facility.

By: Charlie Sternberg

Online Exclusives

CDMO Capacity: Stainless by Volume, Single-Use by Number

Large stainless-steel projects are rising, but pipeline demand is increasingly moving toward smaller, more flexible manufacturing models.

By: Dan Stanton

Sponsored Videos

Cohance Lifesciences: A Global CDMO Platform with Multi-Modality Expertise

Small Molecules. ADCs. Nucleic Acid Chemistry.

Released By Cohance Lifesciences

Breaking News

Fareva Expands CDMO Network With Türkiye Site

The Lüleburgaz facility adds major production capacity, technical expertise, and international client reach.

By: Charlie Sternberg

Promotions & Moves

Symbiosis Names Jos Vergeest Senior Business Development Director

Former GSK, AstraZeneca and CDMO executive joins to support international growth.

By: Charlie Sternberg

Breaking News

CordenPharma Expands Injectable Manufacturing in Italy

The CDMO is adding new property, aseptic fill-finish lines, packaging capacity, and analytical capabilities at its Caponago site near Milan.

By: Charlie Sternberg

Features

Inside the Changing HPAPI Manufacturing Landscape

Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.

By: Charlie Sternberg

Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius

The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.

By: Tim Wright

Breaking News

PerkinElmer Completes SimoTech Acquisition

Deal expands PerkinElmer’s automation, GMP IT and digital manufacturing capabilities for life sciences customers.

By: Charlie Sternberg